Grail Archives -

News/ News/ News/ Oncology/ Sales and Marketing

Commission can rule on Illumina, Grail merger, says EU court

Phil Taylor antitrust, diagnostics, European Commission, Galleri, Grail, Illumina, litigation, M&A, Oncology 0 Comment

Illumina’s attempt to prevent the European Commission from carrying out an antitrust review of its $8 billion takeover

Commission can rule on Illumina, Grail merger, says EU court

https://pharmaphorum.com/news/commission-can-rule-on-illumina-grail-merger-says-eu-court/

R&D/ Views & Analysis/ Views and analysis

Early detection of cancers will require blood sweat and tears

mike.hammerton@pharmaphorum.com Biosignatures, cancer screening, diagnostics, Galleri, Grail, NHS, Sneeden Campbell 0 Comment

An NHS study of a new cancer blood test holds huge promise, but will not be without its

Early detection of cancers will require blood sweat and tears

https://pharmaphorum.com/r-d/galleri-test-nhs-early-detection-cancers/

News/ News/ Patients/ Top stories

NHS England starts largest ever trial of Galleri cancer blood test

Phil Taylor cancer screening, diagnostic, Galleri, Grail, Illumina, liquid biopsy, NHS, NHS England, Oncology 0 Comment

A blood test called Galleri that could detect dozens of different forms of cancer before symptoms appear will

NHS England starts largest ever trial of Galleri cancer blood test

https://pharmaphorum.com/news/nhs-england-starts-largest-ever-trial-of-galleri-cancer-blood-test/

News/ News/ Oncology

Illumina wants to bring liquid biopsy spinout Grail back in-house; report

Phil Taylor diagnosis, Grail, Illumina, liquid biopsy, M&A, Oncology 0 Comment

Cancer diagnosis firm Grail could be re-joining Illumina, the company it was spun out of in 2016, despite

Illumina wants to bring liquid biopsy spinout Grail back in-house; report

https://pharmaphorum.com/news/illumina-wants-to-bring-liquid-biopsy-spinout-grail-back-in-house-report/

Digital and Social Media/ Market Access/ News/ News/ News/ Oncology/ UK & Europe

Cancer blood test firm Grail mulls IPO

Richard Staines biomarker, cancer, digitalhealth, Grail, IPO 0 Comment

Grail, the US-based cancer detection startup backed by billionaires Jeff Bezos and Bill Gates is reportedly mulling a launch on the Hong Kong stock exchange.

Cancer blood test firm Grail mulls IPO

https://pharmaphorum.com/news/cancer-blood-test-firm-grail-mulls-hong-kong-ipo/

Cancer/ Digital and Social Media/ News/ US

Ex-Google exec Jeff Huber steps down as GRAIL CEO

Marco Ricci cancer, Grail, Jeff Huber, medtech 0 Comment

Huber takes on new role as vice chairman of Board of Directors.

Ex-Google exec Jeff Huber steps down as GRAIL CEO

https://pharmaphorum.com/news/huber-steps-down-grail/

Healthcare/ News/ US

Google’s Verily opens cancer testing lab

Marco Ricci cancer, Freenome, Google, Grail, screening, Verily 0 Comment

Google’s life sciences arm Verily has opened a cancer testing lab for Freenome – a startup it invested

Google’s Verily opens cancer testing lab

https://pharmaphorum.com/news/verily-cancer-testing/

Articles/ Digital and Social Media/ Views and analysis

Digital health round-up: consumer wearables are lagging

Marco Ricci cancer, digital health, Fitbit, fitness trackers, Grail, liquid biopsies, wearables 0 Comment

There’s a lot more to do before consumer wearables can truly make an impact.

Digital health round-up: consumer wearables are lagging

https://pharmaphorum.com/views-and-analysis/consumer-wearables-lagging/

Trending

Grail

Login